|
|
|
|
|
|
|
|
open access - pdf file
Conclusions: ..... As treatment options expand, the outlook for women with ovarian cancer is at last slowly but steadily improving.
(blogger's note: questions still that need to be answered )eg. Nevertheless, there are no data available to answer the important question of whether bevacizumab can be used in combination with chemotherapy in both the front-line and recurrent setting in the same patient.
Critical Reviews in Oncology/Hematology
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.